These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 34326843)

  • 21. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
    O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
    Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.
    Rehan M; Ahmed F; Howladar SM; Refai MY; Baeissa HM; Zughaibi TA; Kedwa KM; Jamal MS
    Front Immunol; 2021; 12():648250. PubMed ID: 34248936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells.
    Hafezi B; Chan L; Knapp JP; Karimi N; Alizadeh K; Mehrani Y; Bridle BW; Karimi K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.
    Wang G; Qian P; Jackson FR; Qian G; Wu G
    Int J Biochem Cell Biol; 2008; 40(3):461-70. PubMed ID: 17920330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
    Yongzhi X
    Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
    Malireddi RKS; Sharma BR; Kanneganti TD
    Annu Rev Immunol; 2024 Jun; 42(1):615-645. PubMed ID: 38941608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
    Ryabkova VA; Churilov LP; Shoenfeld Y
    Clin Immunol; 2021 Feb; 223():108652. PubMed ID: 33333256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
    Root-Bernstein R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JAK inhibition as a new treatment strategy for patients with COVID-19.
    Huang J; Zhou C; Deng J; Zhou J
    Biochem Pharmacol; 2022 Aug; 202():115162. PubMed ID: 35787993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2.
    Zheng J; Miao J; Guo R; Guo J; Fan Z; Kong X; Gao R; Yang L
    Front Cell Infect Microbiol; 2022; 12():931061. PubMed ID: 35774402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
    Zheng M; Karki R; Williams EP; Yang D; Fitzpatrick E; Vogel P; Jonsson CB; Kanneganti TD
    Nat Immunol; 2021 Jul; 22(7):829-838. PubMed ID: 33963333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
    Waldmann TA; Chen J
    Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations.
    Ravid JD; Leiva O; Chitalia VC
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JAK/STAT: Why choose a classical or an alternative pathway when you can have both?
    Puigdevall L; Michiels C; Stewardson C; Dumoutier L
    J Cell Mol Med; 2022 Apr; 26(7):1865-1875. PubMed ID: 35238133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 (Review).
    Li W; Zhuang Y; Shao SJ; Trivedi P; Zheng B; Huang GL; He Z; Zhang X
    Mol Med Rep; 2024 Mar; 29(3):. PubMed ID: 38240082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
    Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
    J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.